Three years of experience: the Italian registry and safety data updateGianluigi Mancardi, Leandro Provinciali, G. Tedeschi et al.|Neurological Sciences|2010Cited by 32
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective studyKatia Mattarozzi, Luca Vignatelli, Elisa Baldin et al.|International Journal of Clinical Practice|2012Cited by 20
The pharmacovigilance program on natalizumab in Italy: 2 years of experienceG. Tedeschi, Gianluigi Mancardi, Maria Pia Amato et al.|Neurological Sciences|2009Cited by 13
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Jacques-Eric Gottenberg, Célestine Simand et al.|Annals of the Rheumatic Diseases|2026Cited by 5
Quality of life in patients with Clinically Isolated Syndromes or multiple sclerosis: the impact of diagnosis disclosurePaola Milani, Luca Vignatelli, R. Balugini et al.|Unknown|2007Cited by 0